← All Sponsors
SPONSOR

Mahidol University

Total Trials
10
Recruiting
10
Phases
Phase 4, Phase 3

Mahidol University is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Hemorrhagic Stroke, Ischemic Stroke, Subacute Stroke, Chronic Stroke Patient.

The trial portfolio spans Phase 4, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Mahidol University

How many clinical trials has Mahidol University sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by Mahidol University, of which 10 are actively recruiting participants. These trials cover conditions including Hemorrhagic Stroke, Ischemic Stroke, Subacute Stroke. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Mahidol University research focus on?
Mahidol University clinical trials span Hemorrhagic Stroke, Ischemic Stroke, Subacute Stroke, Chronic Stroke Patient, Tuberculosis (TB), and additional conditions. The research pipeline includes Phase 4, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Mahidol University clinical trial?
To participate in a Mahidol University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Mahidol University trials with current recruitment status updated daily.

Clinical Trials by Mahidol University

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology